Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.
about
Function and Regulation of MicroRNAs and Their Potential as Biomarkers in Paediatric Liver DiseaseMyocardial fibrosis: biomedical research from bench to bedside.Micro-RNA-21 (biomarker) and global longitudinal strain (functional marker) in detection of myocardial fibrotic burden in severe aortic valve stenosis: a pilot studyBeyond miR-122: Identification of MicroRNA Alterations in Blood During a Time Course of Hepatobiliary Injury and Biliary Hyperplasia in RatsCharacterization of miRNA-regulated networks, hubs of signaling, and biomarkers in obstruction-induced bladder dysfunctionA Clinical Perspective of Anti-Fibrotic Therapies for Cardiovascular Disease.Urinary MicroRNA-30c-5p and MicroRNA-192-5p as potential biomarkers of ischemia-reperfusion-induced kidney injury.MicroRNAs, heart failure, and aging: potential interactions with skeletal muscle.MicroRNA Biomarkers of Toxicity in Biological Matrices.Epigenetics in Reactive and Reparative Cardiac Fibrogenesis: The Promise of Epigenetic Therapy.Genetics and Genomics of Single-Gene Cardiovascular Diseases: Common Hereditary Cardiomyopathies as Prototypes of Single-Gene Disorders.Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.MicroRNA profiling identifies miR-7-5p and miR-26b-5p as differentially expressed in hypertensive patients with left ventricular hypertrophyCirculating miR-19b and miR-181b are potential biomarkers for diabetic cardiomyopathy.Fibrosis imaging: Current concepts and future directions.Integrated microRNA-mRNA analyses of distinct expression profiles in follicular thyroid tumors.Upregulated miR-29c suppresses silica-induced lung fibrosis through the Wnt/β-catenin pathway in mice.MicroRNAs Association in the Cardiac Hypertrophy Secondary to Complex Congenital Heart Disease in Children.Regulation of miR-29b and miR-30c by vitamin D receptor activators contributes to attenuate uraemia-induced cardiac fibrosis.miR-192-5p mediates hypoxia/reoxygenation-induced apoptosis in H9c2 cardiomyocytes via targeting of FABP3.Parallel Genome-wide Profiling of Coding and Non-coding RNAs to Identify Novel Regulatory Elements in Embryonic and Maturated Heart.MicroRNA-296: a promising target in the pathogenesis of atherosclerosis?Circulating microRNAs -192 and -194 are associated with the presence and incidence of diabetes mellitusDistinct Anti-Fibrotic Effects of Exosomes Derived from Endothelial Colony-Forming Cells Cultured Under Normoxia and Hypoxia
P2860
Q28073703-20095438-7475-4DB7-9AF5-1466C1808925Q30362840-E9256663-F59C-4A3E-9F17-919AAE38D57FQ30375735-0412CA38-CD2A-4880-ADC1-D9D128D37F6DQ37228567-F6F15368-F05D-48A8-8A2C-4308890596A8Q37599555-72D1A9C5-4ECD-4179-B233-829C5890AC46Q37739117-A350852A-B670-48D3-A19B-C730FDF575F3Q38722803-B7FB284C-71AD-44B6-A8A0-88C73BBCDDCEQ38888119-5E51B1B8-9115-4423-93F0-9DBD5D1BD15BQ38909827-B4A562E0-8BB0-4709-B043-7518A2C4CA8CQ39018712-4E3292A8-8FEF-4E48-8437-8345269489C6Q39050554-E8BDC3EB-EAF0-4865-98D6-8243535BCB0FQ42515078-8D4DA856-02E3-4D0E-85DD-B3115DEADD55Q42664564-598001BD-6713-4E56-8525-F17D39F45AE1Q42677237-F4E56533-AC0F-4A59-8949-F742800306C0Q47376188-D61304C5-A6AC-45B0-A431-C8F112D279A6Q47552152-C82787E4-101D-4EBA-BD9B-1D9C4B537A8FQ50026210-EDC5DFEC-5972-4B2B-9EC9-34282F5FFC4FQ50446253-AB8003D9-9ACE-497E-B0D5-AE45D4454541Q51025922-8D0AD046-B3FF-4904-8C31-43EB6EFED6EFQ51363751-581F666F-78CA-41C3-A9D0-BEE78845481DQ55405827-D88FE8B3-C280-48A9-A135-0767B65DB20AQ55423858-8ED4114A-E4FC-4815-B7EB-FBFC26F8C48FQ58700390-21201CFE-E814-49FD-81D9-389E991FF3E0Q58762824-356A4509-EFC8-48A6-BBB5-D1ECF685453B
P2860
Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Circulating microRNAs as bioma ...... h hypertrophic cardiomyopathy.
@ast
Circulating microRNAs as bioma ...... h hypertrophic cardiomyopathy.
@en
type
label
Circulating microRNAs as bioma ...... h hypertrophic cardiomyopathy.
@ast
Circulating microRNAs as bioma ...... h hypertrophic cardiomyopathy.
@en
prefLabel
Circulating microRNAs as bioma ...... h hypertrophic cardiomyopathy.
@ast
Circulating microRNAs as bioma ...... h hypertrophic cardiomyopathy.
@en
P2093
P2860
P1476
Circulating microRNAs as bioma ...... h hypertrophic cardiomyopathy.
@en
P2093
Andrew J Taylor
Andris H Ellims
Anthony M Dart
David A White
Jaye Chin-Dusting
Xiao-lei Moore
P2860
P2888
P356
10.1186/S12967-015-0672-0
P577
2015-09-24T00:00:00Z
P5875
P6179
1027901680